Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle
Tóm tắt
In recent years, nitric oxide (NO), a gas previously considered to be a potentially toxic chemical, has been established as a diffusible universal messenger that mediates cell–cell communication throughout the body. Constitutive and inducible NO production regulate numerous essential functions of the gastrointestinal mucosa, such as maintenance of adequate perfusion, regulation of microvascular and epithelial permeability, and regulation of the immune response. Up‐regulation of the production of NO via expression of inducible nitric oxide synthase (iNOS) represents part of a prompt intestinal antibacterial response; however, NO has also been associated with the initiation and maintenance of inflammation in human inflammatory bowel disease (IBD). Recent studies on animal models of experimental IBD have shown that constitutive and inducible NO production seems to be beneficial during acute colitis, but sustained up‐regulation of NO is detrimental. This fact is also supported by studies on mice genetically deficient in various NOS isoforms. However, the mechanism by which NO proceeds from being an indispensable homeostatic regulator to a harmful destructor remains unknown. Furthermore, extrapolation of data from animal colitis models to human IBD is questionable. The purpose of this review is to update our knowledge about the role of this universal mediator and the enzymes that generate it in the pathogenesis of IBD.
Từ khóa
Tài liệu tham khảo
Morris SM, 1994, New insights into the regulation of inducible nitric oxide synthesis, Am J Physiol, 266, E829
Moncada S, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109
Grisham MB, 1999, Nitric oxide – I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation, Am J Physiol Gastrointest Liver Physiol, 39, G315, 10.1152/ajpgi.1999.276.2.G315
Kubes P, 1995, Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine, Am J Physiol, 269, G34
Kubes P, 1992, Nitric oxide modulates epithelial permeability in the feline small intestine, Am J Physiol, 262, G1138
Kanwar S, 1994, Nitric oxide synthesis inhibition increases epithelial permeability via mast cells, Am J Physiol, 266, G222
Brown JF, 1993, Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells, Am J Physiol, 265, G418
Tepperman BL, 1993, Nitric oxide synthase induction and intestinal epithelial cell viability in rats, Am J Physiol, 265, G214
Boughton‐Smith NK, 1994, Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease, J R Soc Med, 87, 312, 10.1177/014107689408700602
Kolios G, 1998, Mediators of inflammation: production and implication in inflammatory bowel disease, Hepatogastroenterology, 45, 1601
Kolios G, 2000, Interleukin‐13 inhibits nitric oxide production in human colonic mucosa, Hepatogastroenterology, 47, 714
Kubes P, 1993, Ischemia‐reperfusion in feline small intestine: a role for nitric oxide, Am J Physiol, 264, G143
Payne D, 1993, Nitric oxide donors reduce the rise in reperfusion‐induced intestinal mucosal permeability, Am J Physiol, 265, G189
Miller MJ, 1993, Amelioration of chronic ileitis by nitric oxide synthase inhibition, J Pharmacol Exp Ther, 264, 11
Hogaboam CM, 1995, The selective beneficial effects of nitric oxide inhibition in experimental colitis, Am J Physiol, 268, G673
Yamaguchi T, 2001, Differing effects of two nitric oxide synthase inhibitors on experimental colitis, Hepatogastroenterology, 48, 118
Zingarelli B, 1998, Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid‐induced colonic damage in rats, J Pharmacol Exp Ther, 287, 1048
Kankuri E, 2001, Suppression of acute experimental colitis by a highly selective inducible nitric‐oxide synthase inhibitor, N‐[3‐(aminomethyl) benzyl]acetamidine, J Pharmacol Exp Ther, 298, 1128
Seifter E, 1978, Arginine: an essential amino acid for injured rats, Surgery, 84, 224
Vodovotz Y, 1999, Regulation of transforming growth factor beta 1 by nitric oxide, Cancer Res, 59, 2142